 trials of CAS
can be extrapolated to real-world experience. In general,
physicians who performed carotid stenting in these trials
were highly experienced and their outcomes were rigorously assessed before they were allowed to enroll patients.204 By contrast, in a review of physicians treating
Medicare beneÔ¨Åciaries with CAS, fewer than 10% would
meet criteria to participate in CREST based on low volume or high complication rate.205 It is unclear if